Company Overview of Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the discovery and development of small-molecule antiviral therapeutics for hepatitis C virus (HCV). Its product pipeline includes PPI-668, a pan-genotypic HCV NS5A inhibitor for the treatment of patients with chronic HCV; and PPI-383, a non-nucleoside polymerase inhibitor to treat HCV. Presidio Pharmaceuticals, Inc. was incorporated in 2006 and is based in San Francisco, California.
1700 Owens Street
San Francisco, CA 94158
Founded in 2006
Key Executives for Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Univera, Inc.||United States|
|RiboCor, Inc.||United States|
|MariCal, LLC||United States|
|Ercole Biotech, Inc.||United States|
Recent Private Companies Transactions
April 5, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Princeton, NJ | RGPPosted: Oct 21
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
- Toledo, OH | Research Recruiting AssociationPosted: Dec 09
Sponsored Financial Commentaries
To contact Presidio Pharmaceuticals, Inc., please visit www.presidiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.